Going Public in Canada: Advantages and Advice for U.S. Cannabis Companies Guest post by Cam Mingay, senior partner in the Securities Group and Rowan Groenewald, associate in the Business...
Emerald Health Pharmaceuticals has filed a Tier II Reg A+ preliminary prospectus seeking to raise $50 million by selling up to 10 million shares at $5 per share. The...
After initially filing its preliminary prospectus in April, ACMPR licensed producer MedReleaf (TSX: LEAF) has filed the final prospectus for its $100.7mm initial public offering and secondary offering, selling shares...
After filing its preliminary prospectus for its pending IPO last month, MedReleaf revised it on May 9th, sharing a lot more information. The Canadian cannabis deal, underwritten by GMP...
The list of Canadian licensed producers (LPs) of cannabis expecting to go public just got longer. CanniMed Therapeutics, the parent of CanniMed Ltd. and Prairie Plant Systems, issued a press...
